|
| Male patients with HCV | Female patients with HCV | p value |
| Age (years) Mean ± SD Median (IQR) |
51.19 ± 13.55 56 (49 - 62) |
51.17 ± 14.29 55 (41 - 62) | 0.623 |
| BMI Mean ± SD Median (IQR) |
26.76 ± 3.95 24 (26 - 28) |
28.61 ± 4.07 25 (28 - 31) | 0.000 |
| WBCs (×103/mL) Mean ± SD Median (IQR) |
6.64 ± 2.34 6.2 (4.8 - 8.5) |
6.50 ± 2.26 6.2 (4.9 - 8) | 0.401 |
| Hemoglobin (g/dL) Mean ± SD Median (IQR) |
15.03 ± 1.44 15.2 (14.2 - 15.9) |
13.77 ± 1.52 13.9 (13 - 14.8) | 0.000 |
| Platelets count (×103/mL) Mean ± SD Median (IQR) |
213.68 ± 67.89 201 (171 - 238) |
235 ± 82.61 227 (174 - 271) | 0.000 |
| ALT (U/L) Mean ± SD Median (IQR) |
53.77 ± 37.86 45 (31 - 77) |
51.74 ± 55.68 42 (31 - 70) | 0.385 |
| AST (U/L) Mean ± SD Median (IQR) |
54.96 ± 37.06 43 (37 - 73) |
55.10 ± 43.69 40 (33 - 68) | 0.421 |
| Albumin (g/dL) Mean ± SD Median (IQR) |
4.08 ± 0.48 4 (3.7 - 4.4) |
3.9 ± 0.455 3.9 (3.6 - 4.2) | 0.000 |
| Prothrombin time (Sec) Mean ± SD Median (IQR) |
13.05 ± 1.48 12.9 (12 - 14.5) |
12.50 ± 1.20 12.20 (11.30 - 13) | 0.04 |
| Total bilirubin m (g/dL) Mean ± SD Median (IQR) |
0.69 ± 0.32 0.68 (0.2 - 2.20) |
0.61 ± 0.31 0.6 (0.2 - 1.87) | 0.004 |
| PCR (IU/mL) Mean ± SD Median (IQR)
|
2.16 ± 2.6 × 106 9.4 × 105 (2.57 × 105 - 2.68 × 106) |
1.98 ± 2.2 × 106 8.22 × 105 (3.02 × 105 - 2.54 × 106) | 0.596 |
| Stage of hepatic fibrosis: n (%) within fibrosis stage F0 F1 F2 F3 F4 |
87 (50.9%) 116 (60.7%) 100 (57.5%) 46 (67.6%) 85 (49.7%) |
84 (49.1%) 75 (39.3%) 74 (42.5%) 22 (32.4%) 86 (50.35) | 0.037 |